Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3781525, 5 pages
https://doi.org/10.1155/2017/3781525
Clinical Study

Role of FGF23 in Pediatric Hypercalciuria

1Pediatric Nephrology Unit, Clinics Hospital, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
2Pediatric Nephrology Unit, The Nephrology Center, Santa Casa de Belo Horizonte Hospital, Belo Horizonte, MG, Brazil
3Bone and Mineral Disorders Clinic, Section of Pediatric Nephrology, Children’s Mercy Hospital and Clinics, University of Missouri at Kansas City, Kansas City, MO, USA

Correspondence should be addressed to Maria Goretti Moreira Guimarães Penido; rb.moc.oohay@odinepitterogairam

Received 14 July 2017; Revised 26 September 2017; Accepted 22 October 2017; Published 31 December 2017

Academic Editor: Peyman Björklund

Copyright © 2017 Maria Goretti Moreira Guimarães Penido et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. M. G. Penido, T. Srivastava, and U. S. Alon, “Pediatric primary urolithiasis: 12-year experience at a midwestern children's hospital,” The Journal of Urology, vol. 189, no. 4, pp. 1493–1497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. M. G. Penido, E. M. Lima, V. S. P. Marino, A. L. F. Tupinambá, A. França, and M. F. O. Souto, “Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis,” Pediatric Nephrology, vol. 18, no. 2, pp. 133–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Skalova, V. Palicka, and S. Kutilek, “Bone mineral density and urinary N-acetyl-β-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria,” Nephrology, vol. 10, no. 2, pp. 99–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Asplin, S. Donahue, J. Kinder, and F. L. Coe, “Urine calcium excretion predicts bone loss in idiopathic hypercalciuria,” Kidney International, vol. 70, no. 8, pp. 1463–1467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Worcester and F. L. Coe, “New insights into the pathogenesis of idiopathic hypercalciuria,” Seminars in Nephrology, vol. 28, no. 2, pp. 120–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Sakhaee, N. M. Maalouf, R. Kumar, A. Pasch, and O. W. Moe, “Nephrolithiasis-associated bone disease: pathogenesis and treatment options,” Kidney International, vol. 79, no. 4, pp. 393–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. V. Osorio and U. S. Alon, “The relationship between urinary calcium, sodium, and potassium excretion and the role of potassium in treating idiopathic hypercalciuria,” Pediatrics, vol. 100, no. 4, pp. 675–681, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. U. S. Alon and A. Berenbom, “Idiopathic hypercalciuria of childhood: 4- to 11-year outcome,” Pediatric Nephrology, vol. 14, no. 10-11, pp. 1011–1015, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. U. S. Alon, H. Zimmerman, and M. Alon, “Evaluation and treatment of pediatric idiopathic urolithiasis - Revisited,” Pediatric Nephrology, vol. 19, no. 5, pp. 516–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Telci, A. U. Dogan, E. Ozbek et al., “KLOTHO gene polymorphism of G395A is associated with kidney stones,” American Journal of Nephrology, vol. 33, no. 4, pp. 337–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Worcester and F. L. Coe, “Evidence for altered renal tubule function in idiopathic calcium stone formers,” Urolithiasis, vol. 38, no. 4, pp. 263–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Prié, V. Ravery, L. Boccon-Gibod, and G. Friedlander, “Frequency of renal phosphate leak among patients with calcium nephrolithiasis,” Kidney International, vol. 60, no. 1, pp. 272–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Rendina, G. Mossetti, G. De Filippo, M. Cioffi, and P. Strazzullo, “Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 3, pp. 959–963, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. N. Taylor, A. N. Hoofnagle, and G. C. Curhan, “Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones,” Clinical Journal of the American Society of Nephrology, vol. 10, no. 4, pp. 667–675, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Barcellos Menon, R. M. Affonso Moysés, S. A. Gomes, A. B. De Carvalho, V. Jorgetti, and I. Pfeferman Heilberg, “Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers,” Clinical Journal of the American Society of Nephrology, vol. 9, no. 7, pp. 1263–1270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Srivastava and A. Schwaderer, “Diagnosis and management of hypercalciuria in children,” Current Opinion in Pediatrics, vol. 21, no. 2, pp. 214–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Hellerstein, S. D. Simon, M. Berenbom, P. Erwin, and E. Nickell, “Creatinine excretion rates for renal clearance studies,” Pediatric Nephrology, vol. 16, no. 8, pp. 637–643, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. G. M. G. Penido and U. S. Alon, “Phosphate homeostasis and its role in bone health,” Pediatric Nephrology, vol. 27, no. 11, pp. 2039–2048, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. M. G. Penido and U. S. Alon, “Hypophosphatemic rickets due to perturbations in renal tubular function,” Pediatric Nephrology, vol. 29, no. 3, pp. 361–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Favus, A. J. Karnauskas, J. H. Parks, and F. L. Coe, “Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 10, pp. 4937–4943, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. F. L. Coe, J. H. Parks, A. Evan, and E. Worcester, “Pathogenesis and treatment of nephrolithiasis,” Seldin and Giebisch's The Kidney, pp. 1945–1977, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. Zerwekh, B. Y. Reed, H. J. Heller, G. B. González, M. R. Haussler, and C. Y. C. Pak, “Normal vitamin D receptor concentration and responsiveness to 1,25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria,” Mineral and Electrolyte Metabolism, vol. 24, no. 5, pp. 307–313, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. N. D. Adams, R. W. Gray, J. Lemann Jr., and H. S. Cheung, “Effects of calcitriol administration on calcium metabolism in healthy men,” Kidney International, vol. 21, no. 1, pp. 90–97, 1982. View at Publisher · View at Google Scholar · View at Scopus
  24. W. J. Maierhofer, R. W. Gray, H. S. Cheung, and J. Lemann Jr., “Bone resorption stimulated by elevated serum 1,25-(OH)2vitamin D concentrations in healthy men,” Kidney International, vol. 24, no. 4, pp. 555–560, 1983. View at Publisher · View at Google Scholar · View at Scopus
  25. C. D. Scales, G. E. Tasian, A. L. Schwaderer, D. S. Goldfarb, R. A. Star, and Z. Kirkali, “Urinary stone disease: advancing knowledge, patient care, and population health,” Clinical Journal of the American Society of Nephrology, vol. 11, no. 7, pp. 1305–1312, 2016. View at Publisher · View at Google Scholar
  26. E. N. Taylor, T. T. Fung, and G. C. Curhan, “DASH-style diet associates with reduced risk for kidney stones,” Journal of the American Society of Nephrology, vol. 20, no. 10, pp. 2253–2259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Chang, S. Hoefs, A. W. Van Der Kemp, C. N. Topala, R. J. Bindels, and J. G. Hoenderop, “The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel,” Science, vol. 310, no. 5747, pp. 490–493, 2005. View at Publisher · View at Google Scholar · View at Scopus